Cannabidiol exerts anti-proliferative activity via a cannabinoid receptor 2-dependent mechanism in human colorectal cancer cells

SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor

M Rinaldi-Carmona, Francis Barth, Jean‐Marie Derocq et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 705 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk between Apoptosis and Autophagy

Ashutosh Shrivastava, Paula M. Kuzontkoski, Jerome E. Groopman et al. · Molecular Cancer Therapeutics · 2011 · 446 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors

Mylyne Tham, Orhan Yılmaz, Mariam Alaverdashvili et al. · British Journal of Pharmacology · 2018 · 315 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis

Sean D. McAllister, Ryuichi Murase, Rigel T. Christian et al. · Breast Cancer Research and Treatment · 2010 · 225 citations

Medicine, Cancer Biology, Oncology +12

Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid

Francesca Borrelli, Ester Pagano, Barbara Romano et al. · Carcinogenesis · 2014 · 217 citations · Full text

Medicine, Oncology, Pharmacology +15